Novel vaccine platform to treat Japanese red cedar tree allergy raises $3M A biotechnology company developing a novel vaccine platform to treat people who are allergic to the Japanese Red Cedar and Mountain Cedar trees which holds the potential to combat other allergies has rounded up $3 million, according to a Form D filed with the U.S. Securities and Exchange Commission. Immunomic Therapeutics Inc., a Hershey, Pennsylvania-based [...]
June 14, 2013 - MedCity News